John Cavitt

Company: BlueGen Therapeutics

Job title: Co-Founder & Chief Executive Officer

Seminars:

Preclinical Insights Into Intravitreal Gene Therapy for Rare Retinal Diseases 1:30 pm

Explore the pioneering use of AAV based intravitreal gene therapies for treating Blue Cone Monochromacy and Achromatopsia Examine preclinical data and draw insights from preclinical models to assess the efficacy and safety profiles of intravitreal gene therapy for rare inherited retinal diseases Explore strategies for optimizing the delivery of gene therapies via intravitreal administration such…Read more

day: Day Two 12th